Controladora Vuela CompañÃa de Aviación, S.A.B. de C.V. (VLRS) Bundle
Bradesco Upgrades Volaris to Outperform on Airline Group News
Bradesco upgraded Volaris (NYSE:VLRS) to Outperform on December 22, 2025, following the announcement of a strategic initiative to form a new Mexican airline group with Grupo Viva Aerobus. The stock price rose 14.1% to $9.49 USD, representing an increase of $1.17 USD.
The new airline group aims to expand low-fare travel and enhance connectivity within Mexico and international markets. Both Volaris and Viva Aerobus will maintain their distinct brand identities and operations while seeking economies of scale to strengthen their financial profile. The transaction is subject to regulatory approvals in Mexico and other jurisdictions.
Market data for Volaris (NYSE:VLRS) on December 22, 2025, reflects the following activity:
- Intraday price range: $8.99 USD to $9.99 USD
- 52-week price range: $3.49 USD to $9.99 USD
- Market capitalization: approximately $1.09B USD
- Trading volume: 2,741,176 shares
The company held an investor conference call on December 19, 2025, to discuss the details of the new airline group. Further information regarding the company history and mission is available at VLRS-history-mission-ownership and VLRS-mission-vision.
Additional details on the financial standing and investor relations of the carrier can be found at VLRS-financial-health and VLRS-investor-profile.
Controladora Vuela CompañÃa de Aviación, S.A.B. de C.V. (VLRS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.